120 related articles for article (PubMed ID: 12766573)
1. Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients.
Mandla R; Line PD; Midtvedt K; Bergan S
Ther Drug Monit; 2003 Jun; 25(3):407-14. PubMed ID: 12766573
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
Atcheson BA; Taylor PJ; Mudge DW; Johnson DW; Hawley CM; Campbell SB; Isbel NM; Pillans PI; Tett SE
Br J Clin Pharmacol; 2005 Mar; 59(3):271-80. PubMed ID: 15752372
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
Mino Y; Naito T; Shimoyama K; Ogawa N; Kawakami J
Ann Clin Biochem; 2017 Jul; 54(4):490-494. PubMed ID: 27538768
[TBL] [Abstract][Full Text] [Related]
4. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Weber LT; Lamersdorf T; Shipkova M; Niedmann PD; Wiesel M; Zimmerhackl LB; Staskewitz A; Schütz E; Mehls O; Oellerich M; Armstrong VW; Tönshoff B
Ther Drug Monit; 1999 Oct; 21(5):498-506. PubMed ID: 10519445
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of mycophenolate and its metabolite mycophenolate-7-o-glucuronide with an isocratic HPLC-UV-based method in human plasma and stability evaluation.
Rissling O; Bauer S; Shipkova M; Glander P; Mai M; Hambach P; Budde K
Scand J Clin Lab Invest; 2016 Dec; 76(8):612-619. PubMed ID: 27676419
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
[TBL] [Abstract][Full Text] [Related]
8. Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients.
Naesens M; Kuypers DR; Streit F; Armstrong VW; Oellerich M; Verbeke K; Vanrenterghem Y
Clin Pharmacol Ther; 2006 Nov; 80(5):509-21. PubMed ID: 17112807
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography.
Mino Y; Naito T; Matsushita T; Kagawa Y; Kawakami J
J Pharm Biomed Anal; 2008 Feb; 46(3):603-8. PubMed ID: 18164890
[TBL] [Abstract][Full Text] [Related]
12. Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ozono S; Kagawa Y; Kawakami J
Clin Chim Acta; 2009 Nov; 409(1-2):56-61. PubMed ID: 19723513
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mycophenolic acid and its glucuronide after a single and multiple oral dose of mycophenolate mofetil in Chinese renal transplantation recipients.
Liang MZ; Lu YP; Nan F; Li YP
Transplant Proc; 2006 Sep; 38(7):2044-7. PubMed ID: 16979994
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of mycophenolate mofetil.
Bullingham RE; Nicholls AJ; Kamm BR
Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
[TBL] [Abstract][Full Text] [Related]
15. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material.
Bolon M; Jeanpierre L; El Barkil M; Chelbi K; Sauviat M; Boulieu R
J Pharm Biomed Anal; 2004 Nov; 36(3):649-51. PubMed ID: 15522544
[TBL] [Abstract][Full Text] [Related]
16. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasma and oral fluid concentrations of mycophenolic acid and its glucuronide metabolite by LC-MS in kidney transplant patients.
Ferreira PCL; Thiesen FV; de Araujo TT; D'Ávila DO; Gadonski G; de Oliveira CSA; Zimmer AR; Fröehlich PE
Eur J Clin Pharmacol; 2019 Apr; 75(4):553-559. PubMed ID: 30610275
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Oellerich M; Shipkova M; Schütz E; Wieland E; Weber L; Tönshoff B; Armstrong VW
Ther Drug Monit; 2000 Feb; 22(1):20-6. PubMed ID: 10688252
[TBL] [Abstract][Full Text] [Related]
19. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC-MS/MS assay.
Zhang D; Chow DS; Renbarger JL
Biomed Chromatogr; 2016 Oct; 30(10):1648-55. PubMed ID: 27061819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
